Test Directory
| Test Code | ||||
| ADEVL | ||||
| Test Name | ||||
| Alzheimer Disease Evaluation, CSF | ||||
| CPT Codes | ||||
| 82234, 84393, 84394 | ||||
| Included Tests | ||||
|
||||
| Expected Turnaround Time | ||||
| 1 - 4 days | ||||
| Clinical Utility | ||||
|
Assessment of adults with cognitive impairment being evaluated for Alzheimer disease and other causes of cognitive impairment. These assays should not be used to predict the development of dementia or other neurologic conditions or to monitor response to therapies. |
||||
| Specimen and Container Info | ||||
|
Specimen Type: Cerebrospinal Fluid
Collection Container: Alzheimer's Disease Evaluation CSF Kit Desired Specimen Volume: 2.5 mL |
||||
| Collection Instructions | ||||
|
||||
| Processing and Submission Instructions | ||||
|
||||
| Transport Instructions | ||||
|
Transport to the laboratory refrigerated. |
||||
| Stability Requirements | ||||
|
||||
| Causes for Rejection | ||||
|
||||
| Methodology | ||||
| Electrochemiluminescence (Eclia) | ||||
| Reference Intervals | ||||
|
See patient report. |
||||
| Limitations | ||||
|
A positive cerebrospinal fluid (CSF) beta-amyloid 42 (Abeta42), total Tau (t-Tau), or phosphorylated Tau (p-Tau181) result, or p-Tau181/Abeta42 ratio does not establish a diagnosis of Alzheimer disease (AD) or other cognitive disorder. These results should be interpreted in combination with other clinical diagnostic and radiologic evaluations. |
||||
| Reference Lab | ||||
| Mayo Clinic Laboratories | ||||
| Testing Schedule | ||||
| Routine, 2 times per week | ||||
The American Medical Association (AMA) Current Procedural Terminology (CPT) codes published by HNL Lab Medicine are guidelines and are intended for informational purposes only. CPT coding is the exclusive responsibility of the billing entity. View the Terms.
© 2026 HNL Lab Medicine. All rights reserved.